128 related articles for article (PubMed ID: 38242344)
21. Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
[TBL] [Abstract][Full Text] [Related]
22. LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells.
Laurentino TS; Soares RDS; Lerario AM; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360836
[TBL] [Abstract][Full Text] [Related]
23. Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma.
Cao L; Zhong J; Liu Z; Jiang J; Zhu C; Liu F; Wang B
J Thorac Dis; 2024 Jan; 16(1):581-592. PubMed ID: 38410543
[TBL] [Abstract][Full Text] [Related]
24. Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization.
Canesin G; Cuevas EP; Santos V; López-Menéndez C; Moreno-Bueno G; Huang Y; Csiszar K; Portillo F; Peinado H; Lyden D; Cano A
Oncogene; 2015 Feb; 34(8):951-64. PubMed ID: 24632622
[TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
26. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
28. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
29.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
30. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
[TBL] [Abstract][Full Text] [Related]
31. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of LOXL2 in pancreatic carcinoma.
Rückert F; Joensson P; Saeger HD; Grützmann R; Pilarsky C
Int J Colorectal Dis; 2010 Mar; 25(3):303-11. PubMed ID: 20012301
[TBL] [Abstract][Full Text] [Related]
33. Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability.
Santamaría PG; Floristán A; Fontanals-Cirera B; Vázquez-Naharro A; Santos V; Morales S; Yuste L; Peinado H; García-Gómez A; Portillo F; Hernando E; Cano A
Cell Death Differ; 2018 May; 25(5):935-950. PubMed ID: 29229995
[TBL] [Abstract][Full Text] [Related]
34. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
35. The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection.
Yi X; Zhou Y; Chen Y; Feng X; Liu C; Jiang DS; Geng J; Li X; Jiang X; Fang ZM
Front Cardiovasc Med; 2021; 8():692856. PubMed ID: 34307505
[No Abstract] [Full Text] [Related]
36. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma.
Xu J; Li D; Li X; Liu Z; Li T; Jiang P; He Q; Tian F; Gao Y; Wang D; Wang S
Dig Liver Dis; 2014 Aug; 46(8):750-7. PubMed ID: 24794791
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line.
Zhuang WY; Cen JN; Zhao Y; Chen ZX
Oncol Rep; 2013 Jul; 30(1):185-92. PubMed ID: 23673926
[TBL] [Abstract][Full Text] [Related]
38. Significance of Lysyl oxidase‑like 2 gene expression on the epithelial‑mesenchymal status of hepatocellular carcinoma.
Ninomiya G; Yamada S; Hayashi M; Takeda S; Suenaga M; Takami H; Kanda M; Iwata N; Niwa Y; Tanaka C; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2018 Jun; 39(6):2664-2672. PubMed ID: 29620290
[TBL] [Abstract][Full Text] [Related]
39. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
[TBL] [Abstract][Full Text] [Related]
40. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
